Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.

This is a case report on a successful use of recombinant factor VIIa in treating hematemesis in an 11-month-old infant who suffered with esophageal varices, hepatic dysfunction and previous necrotizing enterocolitis. Prior treatment with platelets, FFP and octreotide did not succeed in controlling the bleeding.

– Maadh Aldouri